Oral formulation of antipsychotic offers 'user-friendly' alternative to injections for patients with acute psychosis

[11 September 2000, Munich] -- Although many physicians rely on intramuscular injections of antipsychotic drugs to treat patients who need emergency treatment for psychotic agitation, new research has found that the oral-solution form of Risperdal™ (risperidone) is just as effective and may be a more acceptable alternative for both caregivers and patients(1).

The study, which was presented today at a major international neuropsychopharmacology congress in Munich, found that Risperdal works as quickly and is as effective in reducing symptoms of psychotic agitation as an intramuscular (IM) injection of haloperidol, an older, conventional antipsychotic. Both medications were administered in combination with the antianxiety drug lorazepam.

"When there are two drugs that are equally efficacious, a physician's next consideration when selecting an antipsychotic drug in emergency situations should be patient choice and compliance," said Dr Glenn Currier, lead investigator and assistant professor of the departments of psychiatry and emergency medicine at the University of Rochester. "When patients experiencing psychotic agitation -- usually due to schizophrenia -- end up in the emergency room, they often are confused, scared and paranoid. Injections are painful, and can be perceived as hostile and 'coercive.' This can be a significant barrier to the physician's ability to deliver good care, and to the patient's ability to accept it."

In contrast, an oral solution (liquid) is more easily administered in emergency situations than pills, and is non-invasive. Patients also can continue on the same medication when they leave the hospital, which encourages long-term compliance. Dr. Currier adds that an oral-solution formulation offers benefits to caregivers as well. Injections expose staff members at hospitals and other facilities to an increased risk of needlepricks and a resultant exposure to diseases such as AIDS and hepatitis -- especially w

Contact: John Gisborne

Page: 1 2 3

Related medicine news :

1. Newer formulation of heparin improves outcomes for suspected heart attack patients
2. Newer vitamin D formulation appears to help dialysis patients live longer
3. Bristol-Meyers Squibb submits NDA for new formulation of once daily videx(R)(didanosine)
4. Researchers warn antipsychotic drug
5. New antipsychotic drugs combined with nicotine patch help schizophrenics quit smoking
6. New study shows prescribing of newer antipsychotic medication risperdal may save millions in schizophrenia care
7. UCSF study offers insight into human circadian rhythms
8. Research offers hope of new treatments for liver damage
9. Portable system offers dialysis patients liberating changes
10. New laparoscopic hysterectomy offers quicker recovery time than traditional surgery
11. UIC offers new weight loss surgery for obese teens

Post Your Comments:

(Date:11/25/2015)... Robles, CA (PRWEB) , ... November 25, 2015 ... ... non-surgical bunion treatment, is offering lower prices in an early celebration of the ... at the promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Dr. Todd S. ... offer laser services to many of his patients. Dr. Afferica now uses the BIOLASE ... reduce the amount of time the doctor uses other traditional cutting tools, such as ...
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, nearly ... year totalling over $358 billion in 2014. With more than 1.5 million U.S. ... who want to “give back” during the holidays. , “With so many charities to ...
(Date:11/24/2015)... ... November 25, 2015 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced that ... Clinical Trial Supply East Asia Conference, to be held at the InterContinental Seoul ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Preparing for ... p.m. – 3:00 p.m. EST, http://www.fdanews.com/preparingldtreg , FDA has long asserted that ... regulations apply to performing the tests and do not meet the device regulations. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... -- st  Scientific Assembly and Annual Meeting of the ... place in Chicago on Nov-29 th ... st  Scientific Assembly and Annual Meeting of the Radiological Society ... Chicago on Nov-29 th through Dec-4 ... Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution ...
(Date:11/24/2015)... LONDON , November 24, 2015 The uptake ... (T1DM), will be a key driver of market growth to 2021, ... of recently approved and pipeline premium products for Type 1 Diabetes Mellitus ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ...
(Date:11/24/2015)... San Diego -based Imprimis Pharmaceuticals, Inc. (NASDAQ: ... the development, production and dispensing of novel compounded ... therapeutic segments including ophthalmology, urology, sinus and integrative ... states from four facilities located in ... New Jersey and Pennsylvania.  ...
Breaking Medicine Technology:
Cached News: